Conference on Retrovirus and Opportunistic Infections (CROI 2024), Denver, Colorado, USA, 3-6 March 2024.

Poster presentations:

• Novel Biomarkers as Determinants of HBsAg Loss in Persons with HIV/HBV on Tenofovir  presented by Lorin Begré on behalf of the EuroSIDA Study Group. POSTER  

IWHOD 2024, Vilamoura, Portugal, 21-23 March 2024

Poster presentations:

• Trends in AIDS-defining illnesses among people living with HIV in Europe: results from the EuroSIDA study (2003-2022) presented by Wendy Bannister on behalf of the EuroSIDA Study Group. POSTER

ECCMID 2024, Barcelona, Spain, 27-30 April 2024

Poster presentations:

• Trends in AIDS-defining illnesses among people living with HIV in Europe: results from the EuroSIDA study (2003-2022) presented by Wendy Bannister on behalf of the EuroSIDA Study Group. POSTER

The 25th International AIDS conference (IAS) 22 - 26 July  2024.

Oral presentation:

• Detailed modeling of viremia exposure does not independently predict cardiovascular diseases in people with HIV, presented by Olof Elvstam on behalf of the RESPOND Study Group.PRESENTATION
•  

Australasian HIV & AIDS conference (ASHM), Sydney, Australia, 16-18 September 2024.

Oral presentation:

Risk of cancer in people with HIV with poor immune recovery despite sustained virological suppression for more than two years on effective antiretroviral treatment, presented by Win Min Han on behalf of the RESPOND Study Group.PRESENTATION